CiDi Reshuffles Board Committees: Dr. Li Xiaoyuan Takes Helm of Nomination Committee

Bulletin Express
08/04

CiDi Inc. (CIDI-NEW) announced adjustments to its board committee structure effective 4 August 2026. Key changes: • Independent non-executive director Dr. Li Xiaoyuan has been promoted from member to chairperson of the Nomination Committee. • Non-executive director Prof. Li Zexiang has relinquished the Nomination Committee chairperson role. • Non-executive director Ms. Yang Xi has joined the Nomination Committee as a member. Board composition: • Executive Directors: Dr. Ma Wei, Dr. Albert S. Hu • Non-executive Directors: Prof. Li Zexiang, Ms. Yang Xi, Dr. Li Zhiyong • Independent Non-executive Directors: Dr. Li Xiaoyuan, Prof. Tan Guangrong, Mr. Zhang Jiangang Latest committee memberships: • Audit Committee: Prof. Tan Guangrong (Chair), Mr. Zhang Jiangang (Member), Ms. Yang Xi (Member) • Remuneration Committee: Prof. Tan Guangrong (Chair), Mr. Zhang Jiangang (Member) • Nomination Committee: Dr. Li Xiaoyuan (Chair), Ms. Yang Xi (Member) The company confirms there are now three independent non-executive directors on the Board, meeting regulatory requirements. Hong Kong serves as the registered location for the August 4 announcement.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10